CanGoNano is a European Training Network funded in the framework of HORIZON Marie Skłodowska-Curie Doctoral Networks (DN).
It is a glycoscience-oriented DN focusing on GlycoNanoMaterials (GNM) as precision tools to unveil key insights on the triggering of the antigen presenting cells against cancer.
CanGoNano assembles an international, multidisciplinary & intersectoral DN of complementary experts on nanotech, glycoscience & immunology to train the next-generation of glyco-nano-scientists on the relevance of understanding the molecular mechanisms of immune system activation at the molecular level to approach the rational design of next-generation cancer vaccines.
The credibility and high quality of CanGoNano are ensured by top-level glycoscientists from 12 academic institutions and 6 industrial partners which encompass complementary and intersectoral expertise, and unique state-of-the-art technological tools to train 14 doctoral candidates (DCs).
The unique combination of scientific excellence in interdisciplinary fields and industry know-how will cover the entire process from obtaining fundamental insights to the implementation of innovative solutions.
CanGoNano aims at creating a critical mass of uniquely skilled graduates in glycan-based therapies. To this aim, we will equip DCs with a thorough multifaceted knowledge of the potential of glycoscience in the discovery of cancer precision therapeutics and the necessary transferable skills. This will put DCs in an advantageous position for job opportunities in both academia and industry. Deciphering the glycome expands the frontiers of knowledge and discovery and enables addressing fundamental challenges in cancer. Therefore, CanGoNano DN will strengthen the European innovation capacity by bringing new glycoscience concepts in the development of cancer precision therapeutics to market and policy stakeholders.
Decipher the molecular mechanisms of APC machinery by a systematic & comparative study
